Subsequent investigation of lysosomal protease processing revealed that CEP treatment impaired the proteolytic maturation of both cathepsin B and cathepsin D in a concentration- and duration-dependent manner across melanoma cell lines (Figure 5D,E). Here, CTSD is linked to melanoma.